DIANA VILLAZON: Open Payments
NPI 1700358108 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 14 payments from 7 companies in 2025. Trend: 2023 $157 · 2024 $551 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $81 |
| Astellas Pharma US Inc | 3 | $77 |
| Exact Sciences Corporation | 2 | $42 |
| Lilly USA, LLC | 2 | $28 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Cranial Technologies, Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Veozah, Wegovy, The Cologuard Plus Collection Kit, MOUNJARO, ROTATEQ, Doc Band, Ozempic, PENMENVY.
Industry payments across FL — which companies pay providers there.
